Adjuvant subcutaneous trastuzumab for HER2-positive early breast cancer: Phase III SafeHer study subgroup analyses of body weights, active medical conditions, safety and tolerability
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Adjuvant subcutaneous trastuzumab for HER2-positive early breast cancer: Phase III SafeHer study subgroup analyses of body weights, active medical conditions, safety and tolerability |
| Type de publication | Journal Article |
| Year of Publication | 2016 |
| Auteurs | Jung K.H, Ataseven B., Verrill M., Pivot X., De Laurentiis M., Al-Sakaff N., Lauer S., Shing M., Gligorov J., Azim H.A |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 27 |
| Date Published | OCT 1 |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |
| DOI | 10.1093/annonc/mdw364.67 |